Sweden· SE-20121208000136
VIZAMYL 400 MBq/ml Injektionsvätska, lösning
A medicinal product containing flutemetamol (18f), registered in Sweden by GE Healthcare AS.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Flutemetamol (18f)
- Manufacturer
- GE Healthcare AS
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20121208000136
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Flutemetamol (18f) in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVIZAMYLGE Healthcare AS, Oslo
- SpainVIZAMYL 400 MBq/ml solucion inyectable Flutemetamol (18F)Ge Healthcare As
- FinlandVizamylGE Healthcare AS
- FranceVIZAMYL 400 MBq/ml, solution injectableGE HEALTHCARE (NORVEGE)
- IrelandVIZAMYL 400 MBq/mL solution for injectionGE Healthcare AS
- NetherlandsVIZAMYL 400 MBq/ml oplossing voor injectieGE Healthcare AS
- United StatesVizamylGE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Vizamyl
- Iceland · Vizamyl
- Liechtenstein · Vizamyl
- Norway · Vizamyl
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/654e06ce-5aff-43e5-a832-5301a225a766 GET /v1/drugs/654e06ce-5aff-43e5-a832-5301a225a766?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20121208000136",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20121208000136",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/vizamyl-epar-product-information_sv.pdf"
}See everything about flutemetamol (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.